SCHEMBL7307246

SCHEMBL7307246

CC(C)(C)OC(=O)NCCc1c[nH]c2ccc(-c3ccc4ccccc4c3)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.56
TRPV1 Q8NER1 3/20 0.56
LTA4H P09960 3/20 0.54
PLA2G2A P14555 3/20 0.54
NQO2 P16083 2/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MTNR1A P48039 3/20 0.50
MTNR1B P49286 2/20 0.50
TRPM8 Q7Z2W7 1/20 0.50
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A1 P04798 1/20 0.49
MPO P05164 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HTR1A P08908 1/20 0.49
CYP2D6 P10635 1/20 0.49
HPGD P15428 1/20 0.49
HTR2B P41595 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7334188 0.91 TRPV1 (0.65) FAAHTRPV1LTA4HPLA2G2AMTNR1A
SCHEMBL7315015 0.86 TRPV1 (0.57) FAAHTRPV1LTA4HPLA2G2AMEN1
SCHEMBL21564239 0.83 IDO1 (0.60) FAAHTRPV1LTA4HPLA2G2AMEN1
SCHEMBL5745010 0.82 MEN1 (0.67) FAAHMEN1KMT2AMTNR1ACYP1A2
SCHEMBL6927448 0.82 MTNR1A (0.74) FAAHTRPV1NQO2MEN1KMT2A
SCHEMBL8613795 0.82 TRPV1 (0.55) FAAHTRPV1NQO2MEN1KMT2A
SCHEMBL798165 0.82 TRPV1 (0.70) TRPV1NQO2MEN1KMT2AKDM4E
SCHEMBL31077788 0.82 TRPV1 (0.70) TRPV1NQO2MEN1KMT2AKDM4E
SCHEMBL7318352 0.81 MTNR1A (0.70) FAAHTRPV1NQO2MEN1KMT2A
SCHEMBL2544150 0.81 HPGD (0.55) FAAHTRPV1NQO2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020004198-A1 Novel anti-infectives SMITHKLINE BEECHAM CORPORATION 2002-01-10 US disclosed
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US disclosed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010007877-A1 NOVEL ANTI-INFECTIVES CTSL, MMP8, SERPINB1 FAAH 3191/4885TRPV1 2884/4885LTA4H 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.